HAMPTON, Va., April 27, 2016 -- Patient Advocate Foundation (PAF), a national nonprofit dedicated to helping those living with serious illness overcome access-to-care issues, is pleased to announce the one-year anniversary of its Metastatic Melanoma and Metastatic Lung Cancer Transportation Financial Aid Fund: a national transportation relief program for qualified patients undergoing recurring IV-infused treatment.
"Transportation continues to be a burden for those requiring frequent access to care across the U.S.," Alan Balch, PhD, CEO of Patient Advocate Foundation says. "We are pleased to continue to offer this resource for patients."
Approved patients receive a one-time grant of $300 to be used specifically for transportation purposes as it applies to the patient's current treatment plan, including but not limited to: ambulance rides, airfare, train, public transportation, taxi or similar service, as well as necessary gas or oil for a vehicle. Patients may also use the funds for car insurance, vehicle repair, auto loans, and vehicle adaptations or modifications such as wheelchair accessibility.
"Our data reveals that when patients do not have access to reliable transportation they are more likely to experience missed or delayed treatment, as well as issues accessing their prescribed medication", Balch adds (1). "By working to eliminate that barrier, we can help patients get and stay on their prescribing physicians' treatment regimen, leading to better health outcomes nationwide."
This program is a part of PAF's Financial Aid Fund division offering targeted relief to specific designated patient populations. Patients interested in applying for the Transportation Financial Aid Fund may call (855) 824-7941 for more information or visit www.patientadvocate.org/programs.
(1) Patient Advocate Foundation, Patient Data Analysis Report, 2015 Edition.
About the Patient Advocate Foundation (PAF) Financial Aid Fund-Patient Advocate Foundation's Financial Aid Fund serves as an independent division of Patient Advocate Foundation, providing small grants to patients who meet the financial and medical criteria. Grants are provided on first-come first served basis and are distributed until funds are depleted. Qualifications and processes for each fund may differ based on fund requirements. Patients who are interested in applying for financial assistance should start by calling this division toll free at (855) 824-7941 or visiting www.patientadvocate.org/programs.
CONTACT: Erin Singleton, Chief of Mission Delivery, Patient Advocate Foundation, 757-952-0561


TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Chinese Cars in Europe: Consumer Trust Is Shifting Fast
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion 



